62
Views
43
CrossRef citations to date
0
Altmetric
Original Article

A Pilot Study of Prophylactic Aerosolized Amphotericin B In Patients at Risk for Prolonged Neutropenia

, , , , , , , & show all
Pages 229-233 | Received 02 Apr 1992, Published online: 01 Jul 2009

References

  • Bodey G. Infections in cancer patients. Cancer Treat. Rev. 1975; 2: 89–128
  • Degregorio M. W., Lee W. M. F., Linker A. Fungal infections in patients with acute leukemia. Am. J. Med. 1982; 73: 543–548
  • Myer R. D., Young L. S., Armstrong D., Yu B. Aspergillosis complicating neoplastic disease. Am. J. Med. 1923; 54: 6–15
  • Bodey G. P., Vartivarian S. Aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 1989; 8: 413–437
  • Morrison V., Haake R., Weisdorf D. The spectrum of non-candida fungal infections in bone marrow transplant patients. Proc. Am. Soc. Clin. One 1991; 10: 1134
  • Young R. C., Bennett J. E., Vogel C. L. Aspergillosis: the spectrum of the disease in 98 patients. Medicine 1970; 49: 147–173
  • Fisher B. D., Armstrong D., Yu B., Gold J. W. M. Invasive aspergillosis: progress in early diagnosis and treatment. Am. J. Med. 1981; 71: 571–577
  • Fraser D. W., Ward J. I., Ajello L., Plikaytis B. D. Aspergillosis and other systemic mycoses: the growing problem. Am. Med. Assoc. 1979; 242: 1621–1635
  • Denning D. W., Stevens D. A. Antifungal and surgical treatment of invasive aspergillosis: review of 2, 121 published cases. Rev. Inf. Dis. 1990; 12: 1147–1201
  • Young L. S. The outlook for antifungal prophylaxis in the compromised host. J. Antimicrob. Chemother. 1982; 9: 338–340
  • Ezdinli E. Z., O'Sullivan D. D., Wasser L. P. Oral amphotericin for candidasis in patients with hematologic neoplasms: an autopsy study. Am. Med. Assoc 1979; 242: 258–60
  • Ann I. M, Prentice H. G., Blacklock H. A. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in early immunocompromised patient. Lancet 1982; 1: 826–829
  • Denning D. W., Tucker R. M., Hanson L. H. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 1989; 86: 791–800
  • Tricot G., Joosten E., Boogaerts M. A. Ketoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev. Inf. Dis. 1987; 9: 594–99
  • Wingard J. R., Vanghan W. P., Braine H. G. Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. Am. J. Med 1987; 83: 1103–1110
  • O'Donnell M. R., Schmidt G. M., Tegtmeir B. Prophylactic low dose amphotericin B decreases systemic fungal infection in allogeneic bone marrow transplant recipients. Blood 1990; 78, 558a (#222-1)
  • Meunier-Carpentier F., Snoeck R., Gerard R. Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with heutropenia. New Engl. J. Med. 1984; 311: 1056
  • Jeffrey G. M., Beard M., Ikram R. B. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am. J. Med. 1991; 90: 685–692
  • Conneally E., Caffekey M. T., Daly P. A. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant 1990; 5: 403–406
  • Schmitt J. H., Bernard E. M., Hauser M., Armstrong D. Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrob Agents. Chemo. Ther. 1988; 32: 1676–1679
  • Hirschel B., Lazzarin A., Chopand P. A controlled study of inhaled pentamadine for primary prevention of pneumoucytis pneumonia. New Engl. Med. 1991; 324: 1079–1083
  • Smith D. W., Frankel L. R., Mathers L. H. A controlled trial of aerosolized ribavinin in infants receiving mechanical ventillation for severe respiratory syntial virus infection. New Engl. Med. 1991; 305: 24–29
  • Hall C. B., McBride J. T., Walsh E. E. Aerosolized ribavirin treatment of infants with respiratory synctial viral infection: a randomized double blind study. New Engl. Med. 1993; 308: 1443–1447
  • Taber L. H., Knight V., Gilbert B. E. Ribavirin aerosol treatment of respiratory viral infection in infants with underlying cardiopulmonary disease. Pediatrics 1983; 72: 613–618
  • Newman S. D. Aerosol deposition considerations in inhalation therapy. Chest 1985; 88: 152S–1605
  • Manufacturer's product information. Baxter Health Care Corporation, Pharmaceal Division, Valencia, CA 1989

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.